Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
EBITDA as a percentage of revenue
Percentile
P18
Within normal range
vs 5Y Ago
-17x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | -309.60% | -215.3% |
| 2024 | -98.19% | -294.1% |
| 2023 | 50.58% | +152.2% |
| 2022 | -96.92% | +47.0% |
| 2021 | -182.96% | -1103.5% |
| 2020 | 18.23% | +138.9% |
| 2019 | -46.86% | +96.0% |
| 2018 | -1167.84% | -68.4% |
| 2017 | -693.32% | -142.3% |
| 2016 | -286.13% | - |